DUBLIN--(BUSINESS WIRE)--The "Monoclonal Antibodies (MAbS) Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The Market Characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
The global monoclonal antibodies (mabs) market is expected to grow from $106.87 billion in 2020 to $114.43 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $179.56 billion in 2025 at a CAGR of 11.9%.
Company Profiles Included:
- Johnson & Johnson
- Merck
- AbbVie
- Amgen
- Glaxosmithkline plc
- Norvatis AG
- Pfizer Inc
- Thermofischer Scientific
- Elililly and Company
- Bristol-Myers Squibb
- Hoffman Roche Ltd
- Sanofi
- Abbott Laboratories
- Mylan N.V
- Novo Nordisk A/S
- Daiichi Sankyo Company ltd.
- Seattle genetics
- Teva pharmaceutical industries
- Shanghi Junsi bioscience ltd
- GenScript
- Sigma-Aldrich Co. LLC
- AbGenomics
- ADC Therapeutics
- Agensys
- Alexion Pharmaceuticals
- ALMAC Group
- Ambrx
- Astellas Pharma
- Celgene
-
Celldex Therapeutics
Key Topics Covered:
1. Executive Summary
2. Monoclonal Antibodies (MAbS) Market Characteristics
3. Monoclonal Antibodies (MAbS) Market Trends And Strategies
4. Impact Of COVID-19 on Monoclonal Antibodies (MAbS)
5. Monoclonal Antibodies (MAbS) Market Size And Growth
6. Monoclonal Antibodies (MAbS) Market Segmentation
7. Monoclonal Antibodies (MAbS) Market Regional And Country Analysis
8. Asia-Pacific Monoclonal Antibodies (MAbS) Market
9. China Monoclonal Antibodies (MAbS) Market
10. India Monoclonal Antibodies (MAbS) Market
11. Japan Monoclonal Antibodies (MAbS) Market
12. Australia Monoclonal Antibodies (MAbS) Market
13. Indonesia Monoclonal Antibodies (MAbS) Market
14. South Korea Monoclonal Antibodies (MAbS) Market
15. Western Europe Monoclonal Antibodies (MAbS) Market
16. UK Monoclonal Antibodies (MAbS) Market
17. Germany Monoclonal Antibodies (MAbS) Market
18. France Monoclonal Antibodies (MAbS) Market
19. Eastern Europe Monoclonal Antibodies (MAbS) Market
20. Russia Monoclonal Antibodies (MAbS) Market
21. North America Monoclonal Antibodies (MAbS) Market
22. USA Monoclonal Antibodies (MAbS) Market
23. South America Monoclonal Antibodies (MAbS) Market
24. Brazil Monoclonal Antibodies (MAbS) Market
25. Middle East Monoclonal Antibodies (MAbS) Market
26. Africa Monoclonal Antibodies (MAbS) Market
27. Monoclonal Antibodies (MAbS) Market Competitive Landscape And Company Profiles
28. Monoclonal Antibodies (MAbS) Pipeline Analysis
29. Key Mergers And Acquisitions In The Monoclonal Antibodies (MAbS) Market
30. Monoclonal Antibodies (MAbS) Market Future Outlook and Potential Analysis
For more information about this report visit https://www.researchandmarkets.com/r/ten7sy
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
